Reid Hoffman is leaving Microsoft’s board to go ‘founder mode’ with startup Manus
After a very profitable decade on Microsoft’s board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.
After a very profitable decade on Microsoft’s board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.
A massive viral conversation sharing VC horror stories has taken place this week on X. Some are weird. Some are infuriating.
Applications for Startup Battlefield 200 officially close on June 8, 11:59 p.m. PT. Now’s not the time to wait any longer. Secure your shot at competing on the Disrupt Stage at TechCrunch Disrupt 2026 this October at San Francisco’s Moscone West.
Lectric, which says the U.S. market is ripe for competition and choice, has launched three new brands in the past six months.
Meta’s board cites “due process” concerns over account bans. It’s also pushing Meta to offer clear information about violations and its use in AI in making its determinations.
If Alphabet’s record-breaking, $85 billion stock sale signals investor appetite for AI-related offerings, we can see that investors are ready to chow.
U.K. regulators are requiring Google offer a tool allowing website publishers to opt-out of generative AI search features. The option will be tested in the U.K. then rolled out globally.
A new reading subscription from Everand offers access to both e-books and audiobooks, and Fable’s book club community.
The caveat is that one of the world’s most famous living directors is using the tech solely for storyboarding.